Journal
BRAIN PATHOLOGY
Volume 24, Issue 4, Pages 396-403Publisher
WILEY
DOI: 10.1111/bpa.12159
Keywords
Alzheimer's disease; amyloid; cerebral amyloid angiopathy; interstitial fluid neuroimmunology; perivascular drainage
Categories
Funding
- Alzheimer's Research UK
- Rosetrees Trust
- BBSRC [BB/K015540/1] Funding Source: UKRI
- Alzheimers Research UK [ARUK-SRF2012-2] Funding Source: researchfish
- Biotechnology and Biological Sciences Research Council [BB/K015540/1] Funding Source: researchfish
Ask authors/readers for more resources
In Alzheimer's disease, amyloid- (A) accumulates as insoluble plaques in the brain and deposits in blood vessel walls as cerebral amyloid angiopathy (CAA). The severity of CAA correlates with the degree of cognitive decline in dementia. The distribution of A in the walls of capillaries and arteries in CAA suggests that A is deposited in the perivascular pathways by which interstitial fluid drains from the brain. Soluble A from the extracellular spaces of gray matter enters the basement membranes of capillaries and drains along the arterial basement membranes that surround smooth muscle cells toward the leptomeningeal arteries. The motive force for perivascular drainage is derived from arterial pulsations combined with the valve effect of proteins present in the arterial basement membranes. Physical and biochemical changes associated with arteriosclerosis, aging and possession of apolipoprotein E4 genotype lead to a failure of perivascular drainage of soluble proteins, including A. Perivascular cells associated with arteries and the lymphocytes recruited in the perivenous spaces contribute to the clearance of A. The failure of perivascular clearance of A may be a major factor in the accumulation of A in CAA and may have significant implications for the design of therapeutics for the treatment of Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available